These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 29410311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD, Guo SJ, Chen SL, Liu ZF, Dong P, Zhang ZL, Jiang LJ, Yao K, Li YH, Han H, Qin ZK, Liu ZW, Zhou FJ.
    Zhonghua Wai Ke Za Zhi; 2017 Aug 01; 55(8):603-607. PubMed ID: 28789511
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L.
    Eur Urol; 2012 Nov 01; 62(5):867-76. PubMed ID: 22938868
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    BJU Int; 2007 May 01; 99(5):993-7. PubMed ID: 17437432
    [Abstract] [Full Text] [Related]

  • 8. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL.
    Urology; 2007 Dec 01; 70(6):1173-8. PubMed ID: 18158041
    [Abstract] [Full Text] [Related]

  • 9. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Mar 20; 25(9):1033-7. PubMed ID: 17261854
    [Abstract] [Full Text] [Related]

  • 10. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
    Williams SB, Kacker R, Steele GS, Richie JP.
    Urol Oncol; 2012 Mar 20; 30(1):60-3. PubMed ID: 20189842
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
    Taza F, Chovanec M, Snavely A, Hanna NH, Cary C, Masterson TA, Foster RS, Einhorn LH, Albany C, Adra N.
    J Clin Oncol; 2020 Apr 20; 38(12):1338-1345. PubMed ID: 32134699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
    Rabbani F, Farivar-Mohseni H, Leon A, Motzer RJ, Bosl GJ, Sheinfeld J.
    Urology; 2003 Dec 20; 62(6):1092-6. PubMed ID: 14665362
    [Abstract] [Full Text] [Related]

  • 17. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A, Carver BS, Stasi J, Bajorin DF, Motzer RJ, Bosl GJ, Sheinfeld J.
    Cancer; 2008 Feb 15; 112(4):800-5. PubMed ID: 18172902
    [Abstract] [Full Text] [Related]

  • 18. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG, Herr HW, Bajorin DF, Bosl GJ.
    Cancer; 1994 Aug 15; 74(4):1329-34. PubMed ID: 8055456
    [Abstract] [Full Text] [Related]

  • 19. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5597-602. PubMed ID: 18065732
    [Abstract] [Full Text] [Related]

  • 20. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS, Cronin AM, Eggener S, Savage CJ, Motzer RJ, Bajorin D, Bosl GJ, Sheinfeld J.
    Urology; 2010 Jun 10; 75(6):1431-5. PubMed ID: 20299079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.